Report Detail

Request for Sample of this report

Chemical & Material Global Ceftriaxone Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM3851094
    • |
  • 26 September, 2024
    • |
  • Global
    • |
  • 125 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Chemical & Material

Ceftriaxone sodium is a cephalosporin antibiotic.
According to our (Global Info Research) latest study, the global Ceftriaxone Sodium market size was valued at US$ 264 million in 2023 and is forecast to a readjusted size of USD 219 million by 2030 with a CAGR of -2.6% during review period.
There are three kinds of Ceftriaxone Sodium, which are ChP, USP and EP. ChP hold the largest share of the Ceftriaxone Sodium market, with a sales market share nearly 74% in 2019.
Ceftriaxone Sodium is used in Single Injection and Compound Injection. The most proportion of Ceftriaxone Sodium is used in Single Injection, and the market share in 2019 is about 96%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 80% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 12%.
For the production, China and India are the mainly manufactured base.
Shandong Ruiying, Qilu Antibiotics, Nectar Lifesciences, Kelun, United Laboratories, Aurobindo Pharma, etc. are the leader of the industry, and top 5 players hold about 50% revenue market share.
This report is a detailed and comprehensive analysis for global Ceftriaxone Sodium market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Ceftriaxone Sodium market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2019-2030
Global Ceftriaxone Sodium market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2019-2030
Global Ceftriaxone Sodium market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2019-2030
Global Ceftriaxone Sodium market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ceftriaxone Sodium
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ceftriaxone Sodium market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shandong Ruiying, Qilu Antibiotics, Nectar Lifesciences, Kelun, United Laboratories, Aurobindo Pharma, Orchid Pharma, Medya Pharma, REYOUNG, LKPC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Ceftriaxone Sodium market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
ChP
USP
EP
Market segment by Application
Single Injection
Compound Injection
Major players covered
Shandong Ruiying
Qilu Antibiotics
Nectar Lifesciences
Kelun
United Laboratories
Aurobindo Pharma
Orchid Pharma
Medya Pharma
REYOUNG
LKPC
ACS Dobfar
NCPC
Dawnrays
Kopran
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ceftriaxone Sodium product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ceftriaxone Sodium, with price, sales quantity, revenue, and global market share of Ceftriaxone Sodium from 2019 to 2024.
Chapter 3, the Ceftriaxone Sodium competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ceftriaxone Sodium breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Ceftriaxone Sodium market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ceftriaxone Sodium.
Chapter 14 and 15, to describe Ceftriaxone Sodium sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Ceftriaxone Sodium Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 ChP
    • 1.3.3 USP
    • 1.3.4 EP
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Ceftriaxone Sodium Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Single Injection
    • 1.4.3 Compound Injection
  • 1.5 Global Ceftriaxone Sodium Market Size & Forecast
    • 1.5.1 Global Ceftriaxone Sodium Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Ceftriaxone Sodium Sales Quantity (2019-2030)
    • 1.5.3 Global Ceftriaxone Sodium Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Shandong Ruiying
    • 2.1.1 Shandong Ruiying Details
    • 2.1.2 Shandong Ruiying Major Business
    • 2.1.3 Shandong Ruiying Ceftriaxone Sodium Product and Services
    • 2.1.4 Shandong Ruiying Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Shandong Ruiying Recent Developments/Updates
  • 2.2 Qilu Antibiotics
    • 2.2.1 Qilu Antibiotics Details
    • 2.2.2 Qilu Antibiotics Major Business
    • 2.2.3 Qilu Antibiotics Ceftriaxone Sodium Product and Services
    • 2.2.4 Qilu Antibiotics Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Qilu Antibiotics Recent Developments/Updates
  • 2.3 Nectar Lifesciences
    • 2.3.1 Nectar Lifesciences Details
    • 2.3.2 Nectar Lifesciences Major Business
    • 2.3.3 Nectar Lifesciences Ceftriaxone Sodium Product and Services
    • 2.3.4 Nectar Lifesciences Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Nectar Lifesciences Recent Developments/Updates
  • 2.4 Kelun
    • 2.4.1 Kelun Details
    • 2.4.2 Kelun Major Business
    • 2.4.3 Kelun Ceftriaxone Sodium Product and Services
    • 2.4.4 Kelun Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Kelun Recent Developments/Updates
  • 2.5 United Laboratories
    • 2.5.1 United Laboratories Details
    • 2.5.2 United Laboratories Major Business
    • 2.5.3 United Laboratories Ceftriaxone Sodium Product and Services
    • 2.5.4 United Laboratories Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 United Laboratories Recent Developments/Updates
  • 2.6 Aurobindo Pharma
    • 2.6.1 Aurobindo Pharma Details
    • 2.6.2 Aurobindo Pharma Major Business
    • 2.6.3 Aurobindo Pharma Ceftriaxone Sodium Product and Services
    • 2.6.4 Aurobindo Pharma Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Aurobindo Pharma Recent Developments/Updates
  • 2.7 Orchid Pharma
    • 2.7.1 Orchid Pharma Details
    • 2.7.2 Orchid Pharma Major Business
    • 2.7.3 Orchid Pharma Ceftriaxone Sodium Product and Services
    • 2.7.4 Orchid Pharma Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Orchid Pharma Recent Developments/Updates
  • 2.8 Medya Pharma
    • 2.8.1 Medya Pharma Details
    • 2.8.2 Medya Pharma Major Business
    • 2.8.3 Medya Pharma Ceftriaxone Sodium Product and Services
    • 2.8.4 Medya Pharma Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Medya Pharma Recent Developments/Updates
  • 2.9 REYOUNG
    • 2.9.1 REYOUNG Details
    • 2.9.2 REYOUNG Major Business
    • 2.9.3 REYOUNG Ceftriaxone Sodium Product and Services
    • 2.9.4 REYOUNG Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 REYOUNG Recent Developments/Updates
  • 2.10 LKPC
    • 2.10.1 LKPC Details
    • 2.10.2 LKPC Major Business
    • 2.10.3 LKPC Ceftriaxone Sodium Product and Services
    • 2.10.4 LKPC Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 LKPC Recent Developments/Updates
  • 2.11 ACS Dobfar
    • 2.11.1 ACS Dobfar Details
    • 2.11.2 ACS Dobfar Major Business
    • 2.11.3 ACS Dobfar Ceftriaxone Sodium Product and Services
    • 2.11.4 ACS Dobfar Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 ACS Dobfar Recent Developments/Updates
  • 2.12 NCPC
    • 2.12.1 NCPC Details
    • 2.12.2 NCPC Major Business
    • 2.12.3 NCPC Ceftriaxone Sodium Product and Services
    • 2.12.4 NCPC Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 NCPC Recent Developments/Updates
  • 2.13 Dawnrays
    • 2.13.1 Dawnrays Details
    • 2.13.2 Dawnrays Major Business
    • 2.13.3 Dawnrays Ceftriaxone Sodium Product and Services
    • 2.13.4 Dawnrays Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Dawnrays Recent Developments/Updates
  • 2.14 Kopran
    • 2.14.1 Kopran Details
    • 2.14.2 Kopran Major Business
    • 2.14.3 Kopran Ceftriaxone Sodium Product and Services
    • 2.14.4 Kopran Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Kopran Recent Developments/Updates

3 Competitive Environment: Ceftriaxone Sodium by Manufacturer

  • 3.1 Global Ceftriaxone Sodium Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Ceftriaxone Sodium Revenue by Manufacturer (2019-2024)
  • 3.3 Global Ceftriaxone Sodium Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Ceftriaxone Sodium by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Ceftriaxone Sodium Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Ceftriaxone Sodium Manufacturer Market Share in 2023
  • 3.5 Ceftriaxone Sodium Market: Overall Company Footprint Analysis
    • 3.5.1 Ceftriaxone Sodium Market: Region Footprint
    • 3.5.2 Ceftriaxone Sodium Market: Company Product Type Footprint
    • 3.5.3 Ceftriaxone Sodium Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Ceftriaxone Sodium Market Size by Region
    • 4.1.1 Global Ceftriaxone Sodium Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Ceftriaxone Sodium Consumption Value by Region (2019-2030)
    • 4.1.3 Global Ceftriaxone Sodium Average Price by Region (2019-2030)
  • 4.2 North America Ceftriaxone Sodium Consumption Value (2019-2030)
  • 4.3 Europe Ceftriaxone Sodium Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Ceftriaxone Sodium Consumption Value (2019-2030)
  • 4.5 South America Ceftriaxone Sodium Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Ceftriaxone Sodium Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Ceftriaxone Sodium Sales Quantity by Type (2019-2030)
  • 5.2 Global Ceftriaxone Sodium Consumption Value by Type (2019-2030)
  • 5.3 Global Ceftriaxone Sodium Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Ceftriaxone Sodium Sales Quantity by Application (2019-2030)
  • 6.2 Global Ceftriaxone Sodium Consumption Value by Application (2019-2030)
  • 6.3 Global Ceftriaxone Sodium Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Ceftriaxone Sodium Sales Quantity by Type (2019-2030)
  • 7.2 North America Ceftriaxone Sodium Sales Quantity by Application (2019-2030)
  • 7.3 North America Ceftriaxone Sodium Market Size by Country
    • 7.3.1 North America Ceftriaxone Sodium Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Ceftriaxone Sodium Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Ceftriaxone Sodium Sales Quantity by Type (2019-2030)
  • 8.2 Europe Ceftriaxone Sodium Sales Quantity by Application (2019-2030)
  • 8.3 Europe Ceftriaxone Sodium Market Size by Country
    • 8.3.1 Europe Ceftriaxone Sodium Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Ceftriaxone Sodium Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Ceftriaxone Sodium Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Ceftriaxone Sodium Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Ceftriaxone Sodium Market Size by Region
    • 9.3.1 Asia-Pacific Ceftriaxone Sodium Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Ceftriaxone Sodium Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Ceftriaxone Sodium Sales Quantity by Type (2019-2030)
  • 10.2 South America Ceftriaxone Sodium Sales Quantity by Application (2019-2030)
  • 10.3 South America Ceftriaxone Sodium Market Size by Country
    • 10.3.1 South America Ceftriaxone Sodium Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Ceftriaxone Sodium Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Ceftriaxone Sodium Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Ceftriaxone Sodium Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Ceftriaxone Sodium Market Size by Country
    • 11.3.1 Middle East & Africa Ceftriaxone Sodium Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Ceftriaxone Sodium Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Ceftriaxone Sodium Market Drivers
  • 12.2 Ceftriaxone Sodium Market Restraints
  • 12.3 Ceftriaxone Sodium Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Ceftriaxone Sodium and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Ceftriaxone Sodium
  • 13.3 Ceftriaxone Sodium Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Ceftriaxone Sodium Typical Distributors
  • 14.3 Ceftriaxone Sodium Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Ceftriaxone Sodium. Industry analysis & Market Report on Ceftriaxone Sodium is a syndicated market report, published as Global Ceftriaxone Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Ceftriaxone Sodium market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,745.72
    		4,118.58
    		5,491.44
    		3,302.52
    		4,953.78
    		6,605.04
    		543,262.80
    		814,894.20
    		1,086,525.60
    		293,955.60
    		440,933.40
    		587,911.20
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo